NASDAQ:ACB Aurora Cannabis Q2 2027 Earnings Date & Estimates $4.06 -0.02 (-0.49%) Closing price 10/30/2026 04:00 PM EasternExtended Trading$4.04 -0.02 (-0.39%) As of 10/30/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Aurora Cannabis is estimated to report Q2 2027 earnings on Thursday, November 12, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ2 2027Announcement DateNovember 12, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Aurora Cannabis in Q2 2027Aurora Cannabis is expected to post earnings of -$0.03 per share on revenue of $50.68 million. In the same quarter a year earlier Aurora Cannabis reported $0.09 per share on revenue of $64.88 million. Aurora Cannabis last reported on August 5, 2026, posting $0.04 per share and beating the -$0.13 consensus estimate. Aurora Cannabis has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.03Expected Revenue$50.68 millionPrior-Year EPS$0.09Prior-Year Revenue$64.88 millionExpected EPS Growth-133.3%Expected Revenue Growth-21.9%Recent Track RecordLast ReportedQ1 2027Last Quarter EPS$0.04 (Beat by +$0.17)Last Quarter Revenue$47.62 millionEPS Beat Rate5 of last 8 quartersPrepare for the Q2 2027 CallEarnings HistoryCompany ProfileQ1 2027 Earnings ReportQ4 2026 Earnings ReportQ3 2026 Earnings Report Aurora Cannabis Q2 2027 Earnings FAQ When does Aurora Cannabis report Q2 2027 earnings? Aurora Cannabis (NASDAQ:ACB) is estimated to report Q2 2027 earnings on Thursday, November 12, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Aurora Cannabis' Q2 2027 earnings call? Aurora Cannabis' Q2 2027 earnings conference call is scheduled for Thursday, November 12, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Aurora Cannabis? Analysts expect Aurora Cannabis to post earnings of -$0.03 per share for Q2 2027. How much revenue is Aurora Cannabis expected to report? The consensus revenue estimate for Aurora Cannabis is $50.68 million for Q2 2027. Aurora Cannabis Earnings HeadlinesAurora Cannabis to Host Second Quarter 2027 Investor Conference CallOctober 29 at 7:50 AM | financialpost.comFCuraleaf Responds to Alberta Securities Commission DecisionOctober 27, 2026 | finance.yahoo.comYour free stock pick for todayElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.October 31 at 1:00 AM | Behind the Markets (Ad)Aurora Cannabis' ATM Program is Ruled As Compliant With Securities LawsOctober 26, 2026 | finance.yahoo.comAurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market ProgramOctober 26, 2026 | prnewswire.comAurora Cannabis (NASDAQ:ACB) vs. BioAge Labs (NASDAQ:BIOA) Head-To-Head ComparisonOctober 26, 2026 | americanbankingnews.comSee More Aurora Cannabis Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email. Email Address About Aurora CannabisAurora Cannabis (NASDAQ:ACB) is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2013, the company develops, produces, distributes and sells cannabis and cannabis-derived products for medical and adult-use markets. Its shares trade on the Toronto Stock Exchange and the Nasdaq under the symbol ACB. Aurora’s product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes and other cannabis extracts. The company markets products through brands such as Aurora, San Rafael ’71, Daily Special and CanniMed, with offerings varying by market and applicable regulations. The company serves Canada’s regulated adult-use and medical cannabis markets and has expanded its medical cannabis business internationally. Aurora has supplied medical cannabis in selected markets across Europe, Australia and South America, subject to local licensing and regulations. Miguel Martin has served as Aurora Cannabis’ chief executive officer since 2021.View Aurora Cannabis ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Silicon Shock: Intel's 25% Valuation ResetMarketBeat Week in Review – 10/26 - 10/30DoorDash's $17 Billion Bet on Instacart Faces a Long Regulatory Road AheadAmazon's Record Margins Couldn't Stop the Sell-Off—Here's WhyStarbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?Breaching the Valuation: The Real Reason Fortinet Dropped Upcoming Earnings Marriott International (11/2/2026)Diamondback Energy (11/2/2026)Williams Companies (11/2/2026)Vertex Pharmaceuticals (11/2/2026)Realty Income (11/2/2026)Apple (11/2/2026)Palantir Technologies (11/2/2026)Entergy (11/2/2026)Booking (11/3/2026)Ferrari (11/3/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
